To determine whether I-FABP plasma levels could be used as a marker of the metabolic alterations and inflammatory status associated with obesity, we evaluated the correlation between plasma I-FABP and host metabolic and inflammatory parameters (Fig. 4). Here, FABP2 is linked to obesity due to melanocortin 4 receptor deficiency.